Scale -

  • Ebitda is 3948 Rs Cr; Annual Growth is 19 %; Continuous Growth over 3 years; in Top Quartile
  • PBT is 1180 Rs Cr; Annual Growth is 16 %; Continuous Growth over 3 years; in Top Quartile
  • PAT is 2568 Rs Cr; Annual Growth is 17 %; Continuous Growth over 3 years; in Top Quartile
  • Revenue is 10560 Rs Cr; Continuous Growth over 3 years; in Top Quartile
  • Quarterly Revenue is 3080 Rs Cr; Continuous Growth over 3 Quarters; in Top Quartile

Profitability -

  • PBDIT Margin is 37.38 %; Continuous Growth over 3 years; in Top Quartile
  • PAT Margin is 24.31 %; Continuous Growth over 3 years; in Top Quartile
  • Quarterly Profit margin is 29 %; Continuous Growth over 3 Quarters; in Top Quartile
  • Quarterly Ebitda Margin is 41 %; in Top Quartile

Return -

  • ROCE is 19.37 %; Continuous Growth over 3 years; in Top Quartile
  • ROE is 15.32 %; Continuous Growth over 3 years; in Top Quartile
  • ROA is 12.81 %; in Top Quartile

Efficiency -

  • Operating cash flow is 2738 Rs Cr; Annual Growth is 66 %; Continuous Growth over 3 years; in Top Quartile
  • Inventory Turnover Ratio is 2.94; Continuous Growth over 3 years; in Bottom Quartile
  • Current Ratio is 5.43; in Top Quartile; Continuous Decline over 3 years
  • Quick Ratio is 3.5; in Top Quartile; Continuous Decline over 3 years

Solvancy -

  • Total Debt is 0 Rs Cr; Annual Decline is -100 %; in Bottom Quartile
  • Debt/Equity is 0; in Bottom Quartile
  • Contingent Liabilities is 2336 Rs Cr; Continuous Growth over 3 years; in Top Quartile

Quality -

  • Operating cashflow/ebitda is 69 %; Annual Growth is 39 %; Continuous Growth over 3 years
  • Operating cashflow/PAT is 107 %; Annual Growth is 41 %
  • Change in Inventories/Total Expenses is -4 %; Annual Decline is -165 %; in Bottom Quartile
  • Other Expenses/Total Expenses is 21 %; Continuous Decline over 3 years
  • Exceptional Items/PBT is -2 %; in Bottom Quartile
  • Current Tax/PAT is 34 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector
Major Subsidiaries/Associates
Key Clients

Products

Products
Product details

Operations

Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Piramal vs Syngene vs Divi’s Labs: Kotak sees up to 58% upside in select CRDMO stocks
Read More
  • Past/current
Divi's Laboratories (NSEI:DIVISLAB) Stock Forecast & Analyst Predictions
Read More
  • Past/current
Rs 2,000-5,000 Crore Profit Stocks to Watch in 2026
Read More
  • Past/current
Divis Laboratories Sees Significant Open Interest Surge Amid Mixed Market Signals
Read More
  • Past/current
Missed Divi's Laboratories' Rally? Here's What Holders Saw
Read More
  • Past/current
DIVISLAB Outlook for the Week
Read More
  • Past/current
Divi's Laboratories shares gain as weight loss drug receives EU panel backing
Read More
  • Past/current
Divi’s Labs Gains 2% as Eli Lilly Pill Wins EU Panel Nod
Read More
  • Past/current
News by CNBC TV18 on TradingView, 2026-10-19 — cnbctv:2d58ca753094b:0
Read More
  • Past/current
Divi's Laboratories Share Price falls 2.46%: valuation check
Read More
  • Past/current
Is Divi's Laboratories the Best Stock in Its Sector? A Look at the Numbers
Read More
  • Past/current
Jefferies lists 6 factors that will shape CRDMO winners; Divi’s Labs, Sai Life, Laurus, Anthem among stock
Read More
  • Past/current
Divi's Laboratories
Read More
  • Past/current
Divi's Laboratories Share Price: Price Action and Valuation
Read More
  • Past/current
India's Top 100 Billionaires 2026: Murali Divi's chemistry of wealth
Read More
  • Past/current